1. Home
  2. EXPO vs ALKS Comparison

EXPO vs ALKS Comparison

Compare EXPO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • ALKS
  • Stock Information
  • Founded
  • EXPO 1967
  • ALKS 1987
  • Country
  • EXPO United States
  • ALKS Ireland
  • Employees
  • EXPO N/A
  • ALKS N/A
  • Industry
  • EXPO Professional Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPO Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • EXPO Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • EXPO 4.6B
  • ALKS 4.7B
  • IPO Year
  • EXPO 1990
  • ALKS 1991
  • Fundamental
  • Price
  • EXPO $90.67
  • ALKS $28.50
  • Analyst Decision
  • EXPO Strong Buy
  • ALKS Buy
  • Analyst Count
  • EXPO 1
  • ALKS 11
  • Target Price
  • EXPO $120.00
  • ALKS $36.00
  • AVG Volume (30 Days)
  • EXPO 266.2K
  • ALKS 1.5M
  • Earning Date
  • EXPO 01-30-2025
  • ALKS 02-13-2025
  • Dividend Yield
  • EXPO 1.24%
  • ALKS N/A
  • EPS Growth
  • EXPO 4.07
  • ALKS 55.25
  • EPS
  • EXPO 2.06
  • ALKS 1.97
  • Revenue
  • EXPO $508,598,000.00
  • ALKS $1,505,121,000.00
  • Revenue This Year
  • EXPO $5.52
  • ALKS N/A
  • Revenue Next Year
  • EXPO $5.48
  • ALKS N/A
  • P/E Ratio
  • EXPO $43.88
  • ALKS $14.60
  • Revenue Growth
  • EXPO 2.56
  • ALKS N/A
  • 52 Week Low
  • EXPO $68.70
  • ALKS $22.90
  • 52 Week High
  • EXPO $115.75
  • ALKS $32.88
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 45.84
  • ALKS 41.99
  • Support Level
  • EXPO $86.32
  • ALKS $27.70
  • Resistance Level
  • EXPO $89.63
  • ALKS $29.36
  • Average True Range (ATR)
  • EXPO 2.01
  • ALKS 0.62
  • MACD
  • EXPO 0.48
  • ALKS -0.15
  • Stochastic Oscillator
  • EXPO 90.81
  • ALKS 35.87

About EXPO Exponent Inc.

Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: